Hematology
Outcomes Research in Review
Adjuvant Pembrolizumab Improves Progression-Free Survival in Stage III Melanoma
News
Researchers propose new acute leukemia subtypes
The researchers found genetic similarities between MPAL and other acute leukemias that could help refine treatment options.
News
ASCO addresses financial barriers to cancer clinical trials
ASCO outlines steps for payers and researchers to take to improve patient participation in cancer clinical trials.
Conference Coverage
STORM trial shows response in penta-refractory myeloma
Selinexor and low-dose dexamethasone produced a “clinically meaningful benefit” in the phase 2 trial.
News
Hormonal contraceptive use linked to leukemia risk in offspring
Maternal use of hormonal contraceptives close to pregnancy is associated with a small increase in the risk of nonlymphoid leukemia in offspring....
News
ASCO updates guidance on prophylaxis for adults with cancer-related immunosuppression
Fluoroquinolones are recommended for adults with cancer-related immunosuppression if they are at high risk of infection, according to an updated...
Article
When is the right time to stop treatment?
Patients often face a trade-off of more suffering with a small chance at remission, versus accepting no chance of cure but feeling well for as...
News
CMS finalizes CAR T-cell therapy inpatient payments
Medical associations are disappointed with CMS’s payment structure for CAR T-cell therapy usage, calling it insufficient.
News
Cervical cancer screening recommendations vary by age and risk
Conference Coverage
A new, simple, inexpensive DVT diagnostic aid
NEW ORLEANS – The CBC holds info that outperforms the D-dimer test.